Global Drug Eluting Balloon Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others

By Material;

Polyurethane, Nylon, and Others

By Technology;

Paccocath, FreePac, TransPax, EnduraCoat, and Others

By End User;

Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn533583747 Published Date: June, 2025 Updated Date: July, 2025

Drug Eluting Balloon Market Overview

Drug Eluting Balloon Market (USD Million)

Drug Eluting Balloon Market was valued at USD 767.03 million in the year 2024. The size of this market is expected to increase to USD 2,086.72 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 15.4%.


Global Drug Eluting Balloon Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 15.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)15.4 %
Market Size (2024)USD 767.03 Million
Market Size (2031)USD 2,086.72 Million
Market ConcentrationLow
Report Pages314
767.03
2024
2,086.72
2031

Major Players

  • Medtronic
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical
  • B. Braun Melsungen AG
  • Koninklijke Philips N.V.
  • Opto Circuits (India) Limited
  • Terumo Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Drug Eluting Balloon Market

Fragmented - Highly competitive market without dominant players


The Drug Eluting Balloon (DEB) Market is expanding rapidly, driven by the rising adoption of minimally invasive vascular procedures. Over 62% of patients now qualify for DEB-based therapies, underlining a growing shift from conventional treatment approaches. DEBs are favored for reducing restenosis risk and minimizing the need for prolonged drug regimens post-procedure.

Preference Over Permanent Implants
DEBs are increasingly used as an alternative to drug-eluting stents, particularly in cases involving delicate or small vessels. Approximately 47% of specialists now recommend DEBs where traditional implants fall short. Their non-permanent design enables efficient drug delivery while preserving vessel integrity, boosting their clinical preference.

Technology-Driven Improvements
Recent advancements in drug coating techniques and balloon catheter design are transforming DEB performance. More than 55% of the latest devices incorporate innovations that optimize drug transfer and lesion targeting. These developments enhance procedural outcomes and patient recovery, reinforcing their market demand.

Emphasis on Efficacy and Long-Term Benefits
The DEB market is increasingly influenced by the focus on clinical outcomes and patient safety. Data shows a 28% decrease in repeat interventions with DEB use versus non-drug alternatives. As providers emphasize evidence-based approaches, DEBs continue to demonstrate value in effective and sustained vascular care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Material
    3. Market Snapshot, By Technology
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Drug Eluting Balloon Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Cardiovascular diseases
        2. Minimally invasive procedures
        3. Aging population
        4. Increasing prevalence of coronary artery disease (CAD)
      2. Restraints
        1. Regulatory challenges
        2. Reimbursement limitations
        3. High initial costs
        4. Limited long-term data
      3. Opportunities
        1. Emerging markets
        2. Advanced technology
        3. Minimally invasive procedures
        4. Healthcare infrastructure expansion
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Drug Eluting Balloon Market, By Product Type, 2021 - 2031 (USD Million)
      1. Coronary Drug Eluting Balloon
      2. Peripheral Drug Eluting Balloon
      3. Others
    2. Drug Eluting Balloon Market, By Material, 2021 - 2031 (USD Million)
      1. Polyurethane
      2. Nylon
      3. Others
    3. Drug Eluting Balloon Market, By Technology, 2021 - 2031 (USD Million)
      1. Paccocath
      2. FreePac
      3. TransPax
      4. EnduraCoat
      5. Others
    4. Drug Eluting Balloon Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. CATH Laboratories
      3. Ambulatory Surgery Centers
      4. Others
    5. Drug Eluting Balloon Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic
      2. Becton, Dickinson and Company
      3. Boston Scientific Corporation
      4. Cook Medical
      5. B. Braun Melsungen AG
      6. Koninklijke Philips N.V.
      7. Opto Circuits (India) Limited
      8. Terumo Corporation
  7. Analyst Views
  8. Future Outlook of the Market